Novo Nordisk's Ozempic Pill Fails to Slow Alzheimer's, Amazon Rises, Tesla Jumps

Stock Movers

On this episode of Stock Movers:

- Novo Nordisk (NVO) dropped after a pill version of Ozempic failed to slow the progression of Alzheimer’s disease in a pair of long-shot studies that aimed to open up a new use for blockbuster obesity drugs.

- Amazon (AMZN) is rising. The company says it will spend as much as $50 billion, expanding its capacity to provide artificial intelligence and high-performance computing services to US government entities.

- Tesla (TSLA) shares jumped around 7% on Monday after a Sunday post on X from Elon Musk commenting on the company’s AI chip plans.

See omnystudio.com/listener for privacy information.

2025-11-24 4 min Transcript

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.